ArrayPatch Ltd, a biotechnology firm based in Cork, Ireland, has completed the first close of a €3 million seed funding round. The company focuses on creating microneedle-based therapies and plans to use the new capital to advance the development of ITZ-Dermaptm, a treatment targeting nail fungus.
The funding will support further research and development efforts aimed at bringing this innovative therapeutic option to market, addressing a common and often difficult-to-treat condition.
**Why this matters**
Nail fungus affects a significant portion of the population and can be challenging to treat effectively with existing methods. ArrayPatch’s microneedle technology offers a novel approach that could improve drug delivery and treatment outcomes. The successful seed round indicates investor confidence in the potential of this new therapy.
Source: NewsData